Asset Management
Compare Stocks
5 / 10Stock Comparison
MGLD vs HCSG vs CODI vs AMSF vs KKR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Conglomerates
Insurance - Specialty
Asset Management
MGLD vs HCSG vs CODI vs AMSF vs KKR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Medical - Care Facilities | Conglomerates | Insurance - Specialty | Asset Management |
| Market Cap | $48M | $1.65B | $939M | $571M | $91.40B |
| Revenue (TTM) | $30M | $1.84B | $1.85B | $325M | $19.26B |
| Net Income (TTM) | $-2M | $59M | $-227M | $46M | $2.37B |
| Gross Margin | 72.5% | 13.3% | 43.7% | 47.6% | 41.8% |
| Operating Margin | -22.2% | 3.0% | 1.4% | 17.8% | 2.4% |
| Forward P/E | — | 21.3x | 97.9x | 14.5x | 16.9x |
| Total Debt | $2M | $25M | $1.88B | $491K | $54.77B |
| Cash & Equiv. | $5M | $161M | $68M | $62M | $6M |
MGLD vs HCSG vs CODI vs AMSF vs KKR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| The Marygold Compan… (MGLD) | 100 | 60.8 | -39.2% |
| Healthcare Services… (HCSG) | 100 | 124.2 | +24.2% |
| Compass Diversified (CODI) | 100 | 52.5 | -47.5% |
| AMERISAFE, Inc. (AMSF) | 100 | 61.1 | -38.9% |
| KKR & Co. Inc. (KKR) | 100 | 175.3 | +75.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MGLD vs HCSG vs CODI vs AMSF vs KKR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MGLD is the clearest fit if your priority is bank quality.
- NIM 0.7% vs KKR's 0.0%
HCSG is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs KKR's -11.0%
- 7.3% ROA vs MGLD's -7.6%, ROIC 9.0% vs -18.8%
CODI ranks third and is worth considering specifically for momentum.
- +90.5% vs AMSF's -30.5%
AMSF carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.21, yield 8.4%
- Lower volatility, beta 0.21, Low D/E 0.2%, current ratio 0.32x
- Beta 0.21, yield 8.4%, current ratio 0.32x
- Lower P/E (14.5x vs 97.9x)
KKR is the clearest fit if your priority is long-term compounding.
- 7.3% 10Y total return vs AMSF's 31.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs KKR's -11.0% | |
| Value | Lower P/E (14.5x vs 97.9x) | |
| Quality / Margins | 14.3% margin vs MGLD's -19.3% | |
| Stability / Safety | Beta 0.21 vs KKR's 1.66, lower leverage | |
| Dividends | 8.4% yield, vs KKR's 0.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +90.5% vs AMSF's -30.5% | |
| Efficiency (ROA) | 7.3% ROA vs MGLD's -7.6%, ROIC 9.0% vs -18.8% |
MGLD vs HCSG vs CODI vs AMSF vs KKR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MGLD vs HCSG vs CODI vs AMSF vs KKR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMSF leads in 1 of 6 categories
KKR leads 1 • MGLD leads 0 • HCSG leads 0 • CODI leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KKR is the larger business by revenue, generating $19.3B annually — 638.8x MGLD's $30M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to MGLD's -19.3%. On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $1.8B | $1.8B | $325M | $19.3B |
| EBITDAEarnings before interest/tax | -$3M | $72M | $164M | $58M | $9.0B |
| Net IncomeAfter-tax profit | -$2M | $59M | -$227M | $46M | $2.4B |
| Free Cash FlowCash after capex | -$2M | $139M | $10M | $8M | $7.5B |
| Gross MarginGross profit ÷ Revenue | +72.5% | +13.3% | +43.7% | +47.6% | +41.8% |
| Operating MarginEBIT ÷ Revenue | -22.2% | +3.0% | +1.4% | +17.8% | +2.4% |
| Net MarginNet income ÷ Revenue | -19.3% | +3.2% | -12.3% | +14.3% | +12.3% |
| FCF MarginFCF ÷ Revenue | -11.2% | +7.6% | +0.5% | +2.5% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +6.6% | -5.9% | +10.3% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +140.3% | +175.0% | -5.1% | -8.5% | -1.7% |
Valuation Metrics
Evenly matched — AMSF and KKR each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 72% valuation discount to KKR's 43.8x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than HCSG's 23.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $48M | $1.7B | $939M | $571M | $91.4B |
| Enterprise ValueMkt cap + debt − cash | $46M | $1.5B | $2.7B | $509M | $146.2B |
| Trailing P/EPrice ÷ TTM EPS | -8.07x | 28.47x | -4.09x | 12.29x | 43.81x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.30x | 97.88x | 14.45x | 16.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 23.20x | 15.18x | 8.54x | 20.51x |
| Price / SalesMarket cap ÷ Revenue | 1.60x | 0.90x | 0.50x | 1.80x | 4.75x |
| Price / BookPrice ÷ Book value/share | 2.05x | 3.30x | 1.64x | 2.30x | 1.20x |
| Price / FCFMarket cap ÷ FCF | — | 11.87x | — | 63.96x | 9.60x |
Profitability & Efficiency
Evenly matched — HCSG and AMSF each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-50 for CODI. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CODI's 3.27x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs MGLD's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -9.6% | +11.8% | -49.6% | +9.7% | +3.2% |
| ROA (TTM)Return on assets | -7.6% | +7.3% | -7.3% | +5.6% | +0.6% |
| ROICReturn on invested capital | -18.8% | +9.0% | +1.0% | +21.9% | +0.3% |
| ROCEReturn on capital employed | -26.0% | +7.7% | +2.4% | +16.8% | +0.1% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 7 | 5 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.10x | 0.05x | 3.27x | 0.00x | 0.67x |
| Net DebtTotal debt minus cash | -$3M | -$136M | $1.8B | -$61M | $54.8B |
| Cash & Equiv.Liquid assets | $5M | $161M | $68M | $62M | $6M |
| Total DebtShort + long-term debt | $2M | $25M | $1.9B | $491,000 | $54.8B |
| Interest CoverageEBIT ÷ Interest expense | -4.42x | 33.02x | -0.63x | — | 3.29x |
Total Returns (Dividends Reinvested)
KKR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KKR five years ago would be worth $18,536 today (with dividends reinvested), compared to $3,333 for MGLD. Over the past 12 months, CODI leads with a +90.5% total return vs AMSF's -30.5%. The 3-year compound annual growth rate (CAGR) favors KKR at 28.5% vs MGLD's -11.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.0% | +32.9% | +168.4% | -18.1% | -20.3% |
| 1-Year ReturnPast 12 months | +19.6% | +60.7% | +90.5% | -30.5% | -13.0% |
| 3-Year ReturnCumulative with dividends | -31.1% | +53.6% | -23.3% | -24.7% | +112.2% |
| 5-Year ReturnCumulative with dividends | -66.7% | -17.7% | -33.7% | -17.6% | +85.4% |
| 10-Year ReturnCumulative with dividends | -66.7% | -24.9% | +56.5% | +31.9% | +732.3% |
| CAGR (3Y)Annualised 3-year return | -11.7% | +15.4% | -8.4% | -9.0% | +28.5% |
Risk & Volatility
Evenly matched — MGLD and CODI each lead in 1 of 2 comparable metrics.
Risk & Volatility
MGLD is the less volatile stock with a -0.09 beta — it tends to amplify market swings less than KKR's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CODI currently trades 98.7% from its 52-week high vs AMSF's 62.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.09x | 1.14x | 1.28x | 0.21x | 1.66x |
| 52-Week HighHighest price in past year | $1.38 | $24.39 | $12.64 | $48.54 | $153.87 |
| 52-Week LowLowest price in past year | $0.64 | $12.66 | $4.58 | $29.42 | $82.67 |
| % of 52W HighCurrent price vs 52-week peak | +81.9% | +94.5% | +98.7% | +62.5% | +66.6% |
| RSI (14)Momentum oscillator 0–100 | 48.9 | 63.2 | 73.8 | 40.2 | 51.4 |
| Avg Volume (50D)Average daily shares traded | 17K | 672K | 1.2M | 208K | 6.2M |
Analyst Outlook
Evenly matched — HCSG and AMSF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HCSG as "Hold", CODI as "Hold", AMSF as "Buy", KKR as "Buy". Consensus price targets imply 46.6% upside for AMSF (target: $45) vs 6.2% for HCSG (target: $25). For income investors, AMSF offers the higher dividend yield at 8.39% vs KKR's 0.78%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $24.50 | $15.00 | $44.50 | $141.14 |
| # AnalystsCovering analysts | — | 15 | 14 | 6 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — | +4.0% | +8.4% | +0.8% |
| Dividend StreakConsecutive years of raises | — | 20 | 0 | 0 | 6 |
| Dividend / ShareAnnual DPS | — | — | $0.50 | $2.55 | $0.80 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.7% | +0.0% | +2.1% | +0.1% |
AMSF leads in 1 of 6 categories (Income & Cash Flow). KKR leads in 1 (Total Returns). 4 tied.
MGLD vs HCSG vs CODI vs AMSF vs KKR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MGLD or HCSG or CODI or AMSF or KKR a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -11. 0% for KKR & Co. Inc. (KKR). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 5x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MGLD or HCSG or CODI or AMSF or KKR?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus KKR & Co. Inc. at 43. 8x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 5x.
03Which is the better long-term investment — MGLD or HCSG or CODI or AMSF or KKR?
Over the past 5 years, KKR & Co.
Inc. (KKR) delivered a total return of +85. 4%, compared to -66. 7% for The Marygold Companies, Inc. (MGLD). Over 10 years, the gap is even starker: KKR returned +732. 3% versus MGLD's -66. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MGLD or HCSG or CODI or AMSF or KKR?
By beta (market sensitivity over 5 years), The Marygold Companies, Inc.
(MGLD) is the lower-risk stock at -0. 09β versus KKR & Co. Inc. 's 1. 66β — meaning KKR is approximately -1980% more volatile than MGLD relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 3% for Compass Diversified — giving it more financial flexibility in a downturn.
05Which is growing faster — MGLD or HCSG or CODI or AMSF or KKR?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -11. 0% for KKR & Co. Inc. (KKR). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -1426. 1% for Compass Diversified. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MGLD or HCSG or CODI or AMSF or KKR?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus -19. 3% for The Marygold Companies, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus -22. 2% for MGLD. At the gross margin level — before operating expenses — MGLD leads at 72. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MGLD or HCSG or CODI or AMSF or KKR more undervalued right now?
On forward earnings alone, AMERISAFE, Inc.
(AMSF) trades at 14. 5x forward P/E versus 97. 9x for Compass Diversified — 83. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 46. 6% to $44. 50.
08Which pays a better dividend — MGLD or HCSG or CODI or AMSF or KKR?
In this comparison, AMSF (8.
4% yield), CODI (4. 0% yield), KKR (0. 8% yield) pay a dividend. MGLD, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is MGLD or HCSG or CODI or AMSF or KKR better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 9%, HCSG: -24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MGLD and HCSG and CODI and AMSF and KKR?
These companies operate in different sectors (MGLD (Financial Services) and HCSG (Healthcare) and CODI (Industrials) and AMSF (Financial Services) and KKR (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MGLD is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; CODI is a small-cap income-oriented stock; AMSF is a small-cap deep-value stock; KKR is a mid-cap quality compounder stock. CODI, AMSF, KKR pay a dividend while MGLD, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.